Richard K Prins sold $244k of AMPH
director at Amphastar Pharmaceuticals, Inc.. 5,000 shares at an average of $48.80, traded Nov 12, 2024, filed Nov 13, 2024.
Score components
- +15RoleDirector
- +13Trade size$244k at market
- +5Share of holdings soldSold 14% of holdings
- +15Cluster4 insiders selling within 14 days
- -15Exercise and sellShares came from an option exercise in the same filing
What happened after comparable sells
Same side and tier, against the S&P 500, at 1, 3 and 6 months. Shown to Pro users; the whole table is on the backtest page.
This signal so far: 1m -7.1%, 3m -30.0%, 6m -48.8%.
Price around the trade, and since
From a quarter before the trade to today. The arrow is the trade, the circle the day the filing reached EDGAR, which is the first day anyone outside could act; the dotted line is the S&P 500 rebased to that day's close.
Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value; the dashed line is the close on the filing day, the dotted line SPY rebased to it.Charts by TradingView Lightweight Charts™
Rows in this filing
Every transaction in Form 4 0001415889-24-026756, as filed. Open on EDGAR
| Date | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|
| Nov 12, 2024 | MOption exercise Common Stock | +2,500 | $16.69 | $42k | 36,471 | Nov 13, 2024 |
| Nov 12, 2024 | SOpen-market sale Common Stock | -5,000 | $48.80 | $244k | 31,471 | Nov 13, 2024 |
| Nov 12, 2024 | GGift Common Stock | -1,000 | $0.00 | $0 | 30,471 | Nov 13, 2024 |
| Nov 12, 2024 | MOption exercise Stock Option (right to buy)derivative | -2,500 | $0.00 | $0 | 4,179 | Nov 13, 2024 |
Related signals
Other insiders at Amphastar Pharmaceuticals, Inc. and this insider’s other filings.
| Score | Company | Insider | Value | Holdings | Filed |
|---|---|---|---|---|---|
| 20Weak | Amphastar Pharmaceuticals, Inc. | William J Peters CFO, EVP & TREASURER | $103k 4,139 shares | -2% | |
| 21Weak | Amphastar Pharmaceuticals, Inc. | Rong Zhou SENIOR EVP, PRODUCTION CENTER | $239k 10,000 shares | -6% | |
| 23Weak | AMPHsell Amphastar Pharmaceuticals, Inc. | Rong Zhou SENIOR EVP, PRODUCTION CENTER | $75k 3,187 shares | -2% | |
| 21Weak | Amphastar Pharmaceuticals, Inc. | Rong Zhou SENIOR EVP, PRODUCTION CENTER | $256k 9,787 shares | -7% | |
| 33Weak | Amphastar Pharmaceuticals, Inc. | Floyd F. Petersen director | $108k 4,163 shares | -6% | |
| 23Weak | Amphastar Pharmaceuticals, Inc. | Richard K Prins director | $113k 4,179 shares | -11% | |
| 30Weak | Amphastar Pharmaceuticals, Inc. | Floyd F. Petersen director | $442k 16,679 shares | -18% | |
| 0Weak | Amphastar Pharmaceuticals, Inc. | Floyd F. Petersen director | $13k 500 shares | -1% | |
| 0Weak | Amphastar Pharmaceuticals, Inc. | Floyd F. Petersen director | $14k 500 shares | -1% | |
| 0Weak | Amphastar Pharmaceuticals, Inc. | Floyd F. Petersen director | $15k 500 shares | -1% |
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.